Clinical Trial Update: Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial update for treating locally advanced head and neck cancer with anlotinib combined with chemoradiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Head and Neck Cancer | Phase 4 | Status: UNKNOWN